Accuray Inc logo

ARAY - Accuray Inc Share Price

$4.75 -0.2  -4.4%

Last Trade - 15/01/21

Small Cap
Market Cap £331.4m
Enterprise Value £397.0m
Revenue £276.7m
Position in Universe 3381st / 6543
Unlock ARAY Revenue
Relative Strength (%)
1m +2.95%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -2.55%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
379.8 398.8 383.4 404.9 418.8 382.9 381.7 419.5 +0.2%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 30 September 2020,Accuray Incorporated revenues decreased 5% to $85.3M. Netincome totaled $402K vs. loss of $9.4M. Revenues reflectEurope, Middle East, India and Africa segment decrease of10% to $28.6M, Japan segment decrease of 16% to $12.2M. NetIncome reflects Selling and marketing - decrease of 36% to$8.6M (expense), General & Administrative decrease of 21%to $7.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ARAY Revenue Unlock ARAY Revenue

Net Income

ARAY Net Income Unlock ARAY Revenue

Normalised EPS

ARAY Normalised EPS Unlock ARAY Revenue

PE Ratio Range

ARAY PE Ratio Range Unlock ARAY Revenue

Dividend Yield Range

ARAY Dividend Yield Range Unlock ARAY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ARAY EPS Forecasts Unlock ARAY Revenue
Profile Summary

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Last Annual June 30th, 2020
Last Interim September 30th, 2020
Incorporated February 22, 2001
Public Since February 8, 2007
No. of Shareholders: 193
No. of Employees: 932
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 91,273,683
Free Float (0.0%)
Eligible for
ARAY Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ARAY
Upcoming Events for ARAY
Tuesday 26th January, 2021 Estimate
Q2 2021 Accuray Inc Earnings Release
Monday 26th April, 2021 Estimate
Q3 2021 Accuray Inc Earnings Release
Frequently Asked Questions for Accuray Inc
What is the Accuray Inc share price?

As of 15/01/21, shares in Accuray Inc are trading at $4.75, giving the company a market capitalisation of £331.4m. This share price information is delayed by 15 minutes.

How has the Accuray Inc share price performed this year?

Shares in Accuray Inc are currently trading at $4.75 and the price has moved by 52.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Accuray Inc price has moved by 33.13% over the past year.

What are the analyst and broker recommendations for Accuray Inc?

Of the analysts with advisory recommendations for Accuray Inc, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Accuray Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Accuray Inc next release its financial results?

Accuray Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Accuray Inc dividend yield?

Accuray Inc does not currently pay a dividend.

Does Accuray Inc pay a dividend?

Accuray Inc does not currently pay a dividend.

When does Accuray Inc next pay dividends?

Accuray Inc does not currently pay a dividend.

How do I buy Accuray Inc shares?

To buy shares in Accuray Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Accuray Inc?

Shares in Accuray Inc are currently trading at $4.75, giving the company a market capitalisation of £331.4m.

Where are Accuray Inc shares listed? Where are Accuray Inc shares listed?

Here are the trading details for Accuray Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ARAY
What kind of share is Accuray Inc?

Based on an overall assessment of its quality, value and momentum, Accuray Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Accuray Inc share price forecast 2021?

Shares in Accuray Inc are currently priced at $4.75. At that level they are trading at 40.85% discount to the analyst consensus target price of 0.00.

Analysts covering Accuray Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.022 for the next financial year.

How can I tell whether the Accuray Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Accuray Inc. Over the past six months, the relative strength of its shares against the market has been 93.7%. At the current price of $4.75, shares in Accuray Inc are trading at 78.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Accuray Inc PE Ratio?

The Accuray Inc PE ratio based on its reported earnings over the past 12 months is 33.08. The shares are currently trading at $4.75.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Accuray Inc?

Accuray Inc's management team is headed by:

Elizabeth Davila - IND
Louis Lavigne - CHM
Richard Pettingill - IND
Joshua Levine - PRE
Shigeyuki Hamamatsu - CFO
Beverly Huss - IND
James Hindman - IND
Suzanne Winter - SVP
Patrick Spine - SVP
Jesse Chew - SVP
Anne Le Grand - IND
Jim Dennison - SVP
Who are the major shareholders of Accuray Inc?

Here are the top five shareholders of Accuray Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 6.58% (6.01m shares)
Neuberger Berman, LLC Investment Advisor/Hedge Fund
Percentage owned: 6.13% (5.59m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.61% (5.12m shares)
Archon Capital Management LLC Hedge Fund
Percentage owned: 4.81% (4.39m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 4.63% (4.23m shares)
Similar to ARAY
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.